Publications

5808 Results

What is the standard of care for pelvic lymphadenectomy performed at the time of radical cystectomy? [Editorial]

Authors
SP Lerner;RS Svatek
Journal / Conference
European Urology Apr;75(4):612-614
Year
2019
Research Committee(s)
Genitourinary
PMID
PMID30616946
Study Number(s)
S1011

SWOG S1505: Initial Findings on Eligibility and Neoadjuvant Chemotherapy Experience with mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

Authors
DPS Sohal;S McDonough;S Ahmad;N Gandhi;M Shaalan Beg;A Wang-Gillam;TBA;JL Wade, III;K Guthrie;A Lowy;P Philip;H Hochster
Journal / Conference
J Clin Oncol 37, 2019 (suppl 4; abstr 414); ASCO GI Cancers Symposium (Jan 17-19, 2019, San Francisco, CA), poster
Year
2019
Research Committee(s)
Gastrointestinal
Study Number(s)
S1505

COlorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study (NRG- GI004/SWOG-S1610): A randomized phase III study of mFOLFOX6/bevacizumab combination chemotherapy with or without atezolizumab or atezolizumab monotherapy in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer (mCRC)

Authors
JJ Lee;G Yothers;SA Jacobs;H Sankoff;CH Cohen;K Guthrie;NL Henry;P Ganz;ES Kopetz;PC Lucas;C Allegra;CD Blanke;N Wolmark;H Hochster;T George;M Overman
Journal / Conference
J Clin Oncol 37, 2019 (suppl 4; abstr TPS728); ASCO GI Cancers Symposium (Jan. 17-19, 2019, San Francisco, CA), submitted 9/25/18
Year
2019
Research Committee(s)
Gastrointestinal

Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance)

Authors
V Morales-Oyarvide;C Yuan;A Babic;S Zhang;D Niedzwiecki;JC Brand-Miller;L Sampson-Kent;X Ye;Y Li;L Saltz;RJ Mayer;RB Mowat;R Whittom;A Hantel;A Benson;D Atienza;M Messino;H Kindler;A Venook;S Ogino;K Wu;WC Willet;EL Giovannucci;BM Wolpin;JA Meyerhardt;CS Fuchs;K Ng
Journal / Conference
Journal of the National Cancer Institute Feb 1;111(2):170-179
Year
2019
Research Committee(s)
Gastrointestinal
PMID
PMID30726946
PMC
PMC6376913
Study Number(s)
C89803

Autologous Transplantation as Consolidation for High Risk Aggressive T-Cell Non-Hodgkin's Lymphoma: A SWOG 9704 Intergroup Trial Subgroup Analysis

Authors
Z Al-Mansour;H Li;JR Cook;LS Constine;S Couban;DA Stewart;TC Shea;P Porcu;JN Winter;BS Kahl;S Smith;DC Marcellus;KP Barton;GM Mills;M LeBlanc;L Rimsza;SJ Forman;JP Leonard;RI Fisher;JW Friedberg;PJ Stiff
Journal / Conference
Leukemia and Lymphoma Aug;60(8):1934-1941; Jan 10:1-8. doi: 10.1080/10428194.2018.1563691. [Epub ahead of print]
Year
2019
Research Committee(s)
Lymphoma
PMID
PMID30628511
PMC
PMC6620162
Study Number(s)
S9704

Long-term effects of finasteride on prostate cancer mortality [correspondence]

Authors
P Goodman;C Tangen;A Darke;MS Lucia;L Ford;L Minasian;H Parnes;M Leblanc;IM Thompson
Journal / Conference
New England Journal of Medicine Jan 24;380(4):393-394
Year
2019
Research Committee(s)
Cancer Control
PMID
PMID30673548
PMC
n/a - correspondence/letter to editor
Study Number(s)
SWOG-9217

A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403

Authors
W Stock;S Luger;A Advani;J Yin;R Harvey;C Mullighan;C Willman;N Fulton;K Laumann;M Malnassy;E Paietta;E Parker;S Geyer;K Mrozek;C Bloomfield;B Sanford;G Marcucci;M Liedtke;D Claxton;M Foster;J Bogart;J Grecula;F Appelbaum;H Erba;M Litzow;M Tallman;R Stone;R Larson
Journal / Conference
Blood Apr 4;133(14):1548-1559
Year
2019
Research Committee(s)
Leukemia
PMID
PMID30658992
PMC
PMC6450431
Study Number(s)
C10403

Association of Patient Comorbid Conditions with Cancer Clinical Trial Participation

Authors
J Unger;D Hershman;M Fleury;R Vaidya
Journal / Conference
JAMA Oncology Mar 1;5(3):326-333; Jan 10 [Epub ahead of print]
Year
2019
Research Committee(s)
Cancer Care Delivery
PMID
PMID30629092
PMC
PMC6439841

A Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase versus FOLFIRINOX Alone in Patients with Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Authors
R Ramanathan;S McDonough;P Philip;S Hingorani;Jill Lacy;J Kortmansky;J Thumar;E Chiorean;AF Shields;D Behl;P Mehan;R Gaur;T Seery;K Guthrie;H Hochster
Journal / Conference
Journal of Clinical Oncology May 1 37(13):1062-1069
Year
2019
Research Committee(s)
Gastrointestinal
PMID
PMID30817250
PMC
PMC6494359
Study Number(s)
S1313

Serum levels of TARC, MDC, IL10 and soluble CD163 in the setting of risk adapted therapy for Hodgkin lymphoma: SWOG S0816 correlative study

Authors
E Hsi;H Li;A Nixon;H Schoder;N Bartlett;M Leblanc;S Smith;B Kahl;J Leonard;A Evens;D Scott;L Rimsza;JW Friedberg
Journal / Conference
Blood Apr 18;133(16):1762-1765; Feb 5. pii: blood-2018-08-870915. doi: 10.1182/blood-2018-08-870915. [Epub ahead of print]
Year
2019
Research Committee(s)
Lymphoma
PMID
PMID30723079
PMC
PMC6473498
Study Number(s)
S0816